
    
      This is a multicenter, open-label clinical study of retreatment of subjects seeking lip
      augmentation who received treatment with either PN40082 or Restylane Silk in prior Protocol
      PRO 2018-02. Subjects meeting the inclusion/exclusion criteria will receive a single
      additional treatment with PN40082
    
  